| mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0028 |
0.9 |
| mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
0.0026 |
0.9 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0027 |
0.9 |
| mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
-0.0026 |
0.9 |
| mRNA |
ISOX |
CTRPv2 |
pan-cancer |
AAC |
-0.0022 |
0.9 |
| mRNA |
TW 37 |
GDSC1000 |
pan-cancer |
AAC |
0.0023 |
0.9 |
| mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0019 |
0.9 |
| mRNA |
PIK-93 |
CTRPv2 |
pan-cancer |
AAC |
0.0023 |
0.9 |
| mRNA |
ciclosporin |
CTRPv2 |
pan-cancer |
AAC |
-0.0025 |
0.9 |
| mRNA |
LFM-A13 |
GDSC1000 |
pan-cancer |
AAC |
-0.0022 |
0.9 |